Navigation Links
Is magnetic therapy effective for tinnitus?
Date:9/18/2012

MAYWOOD, Il. - Loyola University Medical Center is studying whether a new form of non-invasive magnetic therapy can help people who suffer debilitating tinnitus (ringing in the ears).

The therapy, transcranial magnetic stimulation (TMS), sends short pulses of magnetic fields to the brain. TMS has been approved since 2009 for patients who have major depression and have failed at least one antidepressant.

The Loyola study will include patients who suffer from both depression and tinnitus. Recent studies have found that about 12 percent of people with chronic tinnitus also suffer depression and anxiety -- a rate three times higher than that of the general population.

Tinnitus is the perception of sound in one or both ears when there is no external source. It can include ringing, hissing, roaring, whistling, chirping or clicking. About 50 million Americans have at least some tinnitus; 16 million seek medical attention and about 2 million are seriously debilitated, according to the American Tinnitus Association. There is no cure.

The perception of phantom sounds can be more pronounced in people who are depressed. Moreover, antidepressant medications can cause tinnitus occasionally, said Dr. Murali Rao, principal investigator of Loyola's TMS tinnitus study.

Several earlier studies have found that TMS can benefit tinnitus patients. Loyola's study is the first to examine patients who suffer from both tinnitus and depression. "The combination of these two conditions can be extremely debilitating," Rao said.

During TMS treatment, the patient reclines in a comfortable padded chair. A magnetic coil, placed next to the left side of the head, sends short pulses of magnetic fields to the surface of the brain. This produces currents that stimulate brain cells. The currents, in turn, affect mood-regulatory circuits deeper in the brain. The resulting changes in the brain appear to be beneficial to patients who suffer depression. Each treatment lasts 35 to 40 minutes.

The study will enroll 10 to 15 patients. Each patient will receive five treatments a week for four to six weeks, for a total of 20 to 30 treatments. Each patient will be evaluated by a physician three times during the treatment course, or more frequently if the doctor deems necessary.

The treatments do not require anesthesia or sedation. Afterward, a patient can immediately resume normal activities, including driving. Studies have found that patients do not experience memory loss or seizures. Side effects include mild headache or tingling in the scalp, which can be treated with Tylenol.

Rao is chair of the Department of Psychiatry and Behavioral Neurosciences of Loyola University Chicago Stritch School of Medicine. His co-investigator in the study is Sam Marzo, MD, medical director of Loyola's Balance and Hearing Center. Other investigators are Matthew Niedzwiecki, MD, a psychiatry resident; and James Sinacore, PhD, a statistician.


'/>"/>

Contact: Jim Ritter
jritter@lumc.edu
708-216-2445
Loyola University Health System
Source:Eurekalert

Related medicine news :

1. New research confirms efficacy of transcranial magnetic stimulation for depression
2. In-utero exposure to magnetic fields associated with increased risk of obesity in childhood
3. KRAS gene mutation and amplification status affects sensitivity to antifolate therapy
4. Antibody therapy prevents gastrointestinal damage following radiation exposure in mice
5. Chemotherapy proves life-saving for some leukemia patients who fail induction therapy
6. Immunotherapy for elderly cancer patients finds new promise in drug combination
7. Therapy exploits addiction of leukemia cells
8. Intensity Modulated Radiation Therapy optimal for localized prostate cancer
9. Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patients
10. Study Casts Doubt on Value of Pricey Prostate Cancer Therapy
11. 19th century therapy for Parkinsons disease may help patients today
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2017)... ... April 22, 2017 , ... Brian Emmer brings more than ... and Business Development at OAKWORKS, Inc. Mr. Emmer is responsible for the ... planning for the company. Recognized industry-wide as a healthcare innovator, Emmer has ...
(Date:4/21/2017)... ... ... at Palm Beach Face is proud to announce that their practice founder, Michael Schwartz ... place on April 23rd, the London Marathon has a long tradition of raising funds for ... EMPOWER, raising money for the international charity, Smile Train. , Started in 1981 ...
(Date:4/21/2017)... ... 21, 2017 , ... Brady (NYSE:BRC), a global leader in industrial ... B-7569 vinyl label materials received certification for the BS5609 British Marine Standard. ... intact and legible, for use on chemical drums shipped by sea. , ...
(Date:4/21/2017)... , ... April 21, 2017 , ... The Patient Advocacy ... Health System, with the 2017 Ruth Ravich Patient Advocacy Award in recognition ... advocates. DeVaro was honored with the award at The Beryl Institute’s annual Patient ...
(Date:4/21/2017)... ... April 21, 2017 , ... The American Medical Student Association ... and Recovery Education, from April 24 to April 28, 2017, dedicated to increasing ... , The mission of AWARE is to instill a compassionate, total health approach ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... DALLAS , April 19, 2017  Vanderbilt University ... first patients in Nashville , Tennesse ... Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. ... to provide long-term reflux control by restoring normal function ... nearly 65 million people in the United ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
(Date:4/18/2017)... Research and Markets has announced the addition ... their offering. ... devices market to grow at a CAGR of 6.35% during the ... 2017-2021, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
Breaking Medicine Technology: